Lilly Feeds The Beast, But Is Novartis Animal Health Unit Worth The Price?
This article was originally published in The Pink Sheet Daily
Executive Summary
$5.4 billion deal boosts Lilly’s Elanco animal health business that adds both geographic scope and better product mix, but some investors snort at the high multiple.